The SURMOUNT-OSA program consisted of two parallel 52-week, Phase 3 trials evaluating Tirzepatide in adults with moderate-to-severe OSA and obesity
3K followersLos Angeles Metropolitan Area Don Roy Don Roy American WaterFactory 883 followersHuntington Beach, CA Hal Truax Hal Truax PCD 5K followersSanta Rosa, CA Steve Jones Steve Jones Meritec Group 650 followersRaleigh, NC Kevin Peterson Kevin Peterson JX Advanced Metals USA, Inc
MicroRNA-9 Ameliorates Destructive Arthritis Through Down-Regulation of NF-b1-RANKL Pathway in Fibroblast-Like Synoviocytes
Developed by the pharmaceutical company Eli Lilly, Zepbound offers a novel approach to weight management by combining the effects of two hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
comparator group: 417) revealed that ALC significantly reduces depressive symptoms compared to placebo, with comparable efficacy to standard antidepressants and fewer adverse effects
Some people may experience quicker results with weight loss or blood pressure control, while others may take longer